Poda’s eCig Alternative Could Catch Fire in the U.S.
Ryan Allway
September 28th, 2021
App, Exclusive, News, Top Story
Most U.S. smokers are familiar with e-cigarettes, like Juul, that offer a nicotine experience. But, unfortunately, their catchy flavors have attracted nonsmokers—including young people—and that has caught the attention of the Food and Drug Administration (FDA). Recent crackdowns threaten to kill the nascent vaping industry, leaving a massive vacuum.
Poda Holdings, Inc. (CSE: PODA) (FSE: 99L) (OTC: PODAF) aims to fill the vacuum with its unique heat-not-burn products. Unlike vapes, the company’s cartridges provide a non-tobacco blend that closely resembles cigarette smoking without producing any smoke and significantly lessens the harmful effects.
Let’s look at how the FDA is cracking down on the vaping industry and why Poda’s e-cigarette alternative could soon gain traction.
Click here to receive an investor presentation and corporate updates
FDA Bans Millions of Vaping Products
The FDA refused to grant marketing approval for millions of vape products after requiring tobacco manufacturers to submit a Pre-Market Tobacco Application (PMTA) for every product they began selling after February 15, 2007. While the FDA primarily denied applications due to missing documentation, the move demonstrates its opposition to vape products.
Under the PMTA, the FDA requires manufacturers to show that their products benefit adult smokers sufficient to overcome the public health threat posed by the rise in youth consumption of such products. These rules are stricter than other non-vaping tobacco products that don’t require evidence that children won’t use them.
In addition to the FDA’s effective bans, Congress is considering a tax hike that could double or triple the prices of nicotine-containing e-liquid. As a result, vape manufacturers may have to decide between cutting margins to razor-thin levels or raising consumer prices, which could slow down demand and take a toll on sales.
Heat-Not-Burn Could Gain Traction
Heat-not-burn products have become extremely popular in Japan and other countries around the world. In essence, these products heat tobacco at temperatures sufficient for a great consumer experience without harmful smoke. Philip Morris, a tobacco giant, believes that HNB products could replace traditional cigarettes within 20 years.
Poda’s Beyond Burn Poda Pods provide a specialized blend of pelletized tea leaves and synthetic nicotine that perfectly mimics tobacco. Since the 2009 Family Smoking Prevention and Tobacco Control Act (TCA) only applies to products derived from tobacco, synthetic nicotine isn’t subject to the same regulations as tobacco products.
While Philip Morris’ IQOS is already on the market, the giant’s HNB product was designed mainly based on its existing manufacturing footprint rather than consumer needs. Poda’s Beyond Burn products feature a far superior user experience, including its patented zero-cleaning and zero-maintenance designs, as well as compostable pods.
Beyond the Tobacco Industry
Poda also designed poda pods to extend beyond the tobacco industry. For example, the same technology could apply to caffeine-infused products, nicotine-free blends, real tobacco, cannabis, CBD, or medicinal herbs. With its zero-smoke technology, consumers don’t have to worry about major carcinogenic risk factors.
At the same time, the company plans to offer white labeling opportunities to increase market share and distribution reach. The business is uniquely suited to compete with industry peers with a low-cost production facility while providing a superior product design to edge out the competition. It’s a win-win-win for consumers, partners, and the company.
Investors may find the business model compelling given its razor-razorblade model. The company’s handheld device lasts for years, while the disposable pods are like cigarettes. As a result, the company can effectively sell the devices at cost and generate long-term, high-margin, recurring income from the sale of poda pods over time.
Looking Ahead
Consumers smoke more than 5.7 trillion legally purchased cigarettes each year. At the same time, consumers are well aware of the health risks posed by ordinary smoking products. E-cigarettes were once hailed as the solution to the problem, but the rise of youth smoking has resulted in the FDA effectively banning millions of these products.
Poda Holdings, Inc. (CSE: PODA) (FSE: 99L) (OTC: PODAF) aims to fill the void left by the vaping products with its unique heat-not-burn technology. With the ability to quickly scale, the company could become a large player in the space or an acquisition target, making it a story that investors should follow over the coming months.
To learn more, visit the company’s website or download their investor presentation.
Click here to receive an investor presentation and corporate updates
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Next Green Wave is a fully integrated premium seed to shelf craft cannabis producer offering products through its in-house brand portfolio and wholesale flower for other large cannabis manufacturers.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
